Sucampo Pharmaceuticals, Inc. 4
4 · Sucampo Pharmaceuticals, Inc. · Filed Apr 2, 2015
Insider Transaction Report
Form 4
Kuno Sachiko
Director10% Owner
Transactions
- Sale
Class A Common Stock
2015-03-31$14.00/sh−353,530$4,949,420→ 0 total(indirect: By Spouse) - Sale
Class A Common Stock
2015-03-31$14.00/sh−1,186,113$16,605,582→ 20,274,689 total(indirect: By LLC) - Sale
Class A Common Stock
2015-03-31$14.00/sh−60,357$844,998→ 0 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected as part of an underwritten public offering in which the reporting person, her husband and S&R Technology Holdings, LLC each participated as a selling stockholder.
- [F2]Dr. Kuno disclaims beneficial ownership of the reported securities.
- [F3]S&R Technology Holdings, LLC is wholly owned by Dr. Kuno and her husband. Dr. Kuno disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.